×
About 9,538 results

ALLMedicine™ Tetanus Center

Research & Reviews  2,761 results

Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fract...
https://doi.org/10.1016/S1473-3099(22)00273-0
The Lancet. Infectious Diseases; Samuels AM, Ansong D et. al.

Jun 27th, 2022 - Controlled infection studies in malaria-naive adults suggest increased vaccine efficacy for fractional-dose versus full-dose regimens of RTS,S/AS01. We report first results of an ongoing trial assessing different fractional-dose regimens in childr...

The Beirut Port Blast: spectrum of injuries and clinical outcomes at a large tertiary c...
https://doi.org/10.1007/s00068-022-02023-9 10.1017/dmp.2020.451 10.1007/s00193-020-00970-z 10.1038/d41586-020-02361-x 10.1186/s12913-020-05906-y 10.1016/S0140-6736(20)31750-5 10.1016/S0140-6736(20)31908-5 10.3389/fpubh.2021.657996
European Journal of Trauma and Emergency Surgery : Offici... El Zahran T, Geha M et. al.

Jun 26th, 2022 - To describe injuries and outcomes of casualties of Beirut Port Blast treated at a large tertiary care center in Beirut, Lebanon. A retrospective observational study assessing the spectrum of injuries, treatment, and medical outcome among casualtie...

Vaccinating Children After Chemotherapy
https://clinicaltrials.gov/ct2/show/NCT02447718

Jun 24th, 2022 - Rationale and Aims: Children with acute lymphoblastic leukemia (ALL) have evidence of persistent immunosuppression following chemotherapy and may experience waning of immunity to vaccines received prior to treatment. There is no standard of care i...

Intervention to Promote Childhood Vaccinations and Influence Vaccination Attitudes
https://clinicaltrials.gov/ct2/show/NCT05425823

Jun 24th, 2022 - Today, vaccines are still recognized as one of the most important public health services, and millions of lives are saved each year. Despite the success of vaccination, such as eradicating certain diseases in the community and preventing epidemics...

Potent anti-tumor immune response and tumor growth inhibition induced by HER2 subdomain...
https://doi.org/10.1007/s00432-022-04084-0 10.1172/JCI200113463 10.2217/imt-2017-0181 10.1038/s41467-019-13438-1 10.1002/ijc.31551 10.1080/1061186X.2017.1387788 10.1007/s00005-019-00566-1 10.1016/j.ccr.2014.02.025 10.3389/fimmu.2013.00114 10.1200/JCO.2006.05.9584 10.1084/jem.186.1.65 10.1158/0008-5472.CAN-10-1322 10.1080/14760584.2018.1434000 10.1158/1078-0432.CCR-09-0737 10.1080/2162402X.2016.1166323 10.1016/j.ctrv.2017.10.005 10.1016/S0264-410X(02)00741-7 10.1089/cbr.2017.2327 10.3389/fimmu.2020.615240 10.1200/JCO.2004.09.005 10.1200/JCO.2009.23.3494 10.1007/s002620050539 10.1016/S0264-410X(00)00493-X 10.1101/gad.314617.118 10.1186/1479-5876-10-28 10.1016/j.vaccine.2005.07.073 10.1038/s41541-019-0103-y 10.18632/oncotarget.2713 10.1007/s10549-005-9108-5 10.1016/j.jconrel.2016.12.012 10.1038/nature01441 10.1111/j.1349-7006.2007.00705.x 10.1158/1078-0432.CCR-06-1546 10.1007/s00262-004-0653-2 10.1007/s00262-010-0869-2 10.1007/s10549-016-3751-x 10.3390/cells3020304 10.1093/annonc/mdt133 10.1371/journal.pone.0243550 10.3390/cancers13194958 10.4236/wjv.2015.52013 10.3390/ijms22020779 10.1002/eji.1830191209 10.1158/0008-5472.CAN-07-5688 10.1200/JCO.2005.03.047 10.4049/jimmunol.171.3.1588 10.1093/annonc/12.suppl_1.S3 10.1126/science.3798106 10.1126/science.2470152 10.1172/JCI23373 10.1073/pnas.95.3.1178 10.4049/jimmunol.175.1.329 10.7314/APJCP.2016.17.3.905 10.2217/imt.13.156 10.1038/s41417-020-0183-x 10.1007/s002620050268 10.1073/pnas.0703395104 10.3389/fimmu.2019.00008 10.1038/cgt.2013.60 10.1016/j.vaccine.2018.01.078 10.3892/ijmm.2014.2000 10.1016/j.jconrel.2019.04.019 10.1016/j.ejca.2020.01.010
Journal of Cancer Research and Clinical Oncology; Ghaedi M, Golsaz-Shirazi F et. al.

Jun 24th, 2022 - Several approaches have so far been employed to establish anti-tumor immunity by targeting HER2 protein. Active immunization with recombinant HER2 subdomains has previously been demonstrated to induce potent immune response and tumor growth inhibi...

see more →

Guidelines  12 results

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poli...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004397
MMWR. Morbidity and Mortality Weekly Report; Oliver SE, Moore KL

Feb 7th, 2020 - On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningo...

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Upd...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367039
MMWR. Morbidity and Mortality Weekly Report; Havers FP, Moro PL et. al.

Jan 24th, 2020 - Since 2005, a single dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine has been recommended by the Advisory Committee on Immunization Practices (ACIP) for adolescents and adults (1,2). After receipt of Tdap,...

ACOG Committee Opinion No. 741 Summary: Maternal Immunization.
https://doi.org/10.1097/AOG.0000000000002665
Obstetrics and Gynecology;

May 26th, 2018 - Immunization is an essential part of care for adults, including pregnant women. Influenza vaccination for pregnant women is especially important because pregnant women who contract influenza are at greater risk of maternal morbidity and mortality ...

Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Re...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919600
MMWR. Recommendations and Reports : Morbidity and Mortali... Liang JL, Tiwari T et. al.

Apr 28th, 2018 - This report compiles and summarizes all recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria, and pertussis in the United States. As a comprehensive summary of previ...

Committee Opinion No. 718: Update on Immunization and Pregnancy: Tetanus, Diphtheria, a...
https://doi.org/10.1097/AOG.0000000000002301
Obstetrics and Gynecology;

Aug 24th, 2017 - The overwhelming majority of morbidity and mortality attributable to pertussis infection occurs in infants who are 3 months and younger. Infants do not begin their own vaccine series against pertussis until approximately 2 months of age. This leav...

see more →

Drugs  101 results see all →

Clinicaltrials.gov  369 results

Intervention to Promote Childhood Vaccinations and Influence Vaccination Attitudes
https://clinicaltrials.gov/ct2/show/NCT05425823

Jun 24th, 2022 - Today, vaccines are still recognized as one of the most important public health services, and millions of lives are saved each year. Despite the success of vaccination, such as eradicating certain diseases in the community and preventing epidemics...

Vaccinating Children After Chemotherapy
https://clinicaltrials.gov/ct2/show/NCT02447718

Jun 24th, 2022 - Rationale and Aims: Children with acute lymphoblastic leukemia (ALL) have evidence of persistent immunosuppression following chemotherapy and may experience waning of immunity to vaccines received prior to treatment. There is no standard of care i...

Immune Response followingTdap Vaccine in Pregnancy
https://clinicaltrials.gov/ct2/show/NCT04082299

Jun 23rd, 2022 - Many vaccine-preventable diseases, like influenza, pertussis, and tetanus cause substantial morbidity and mortality in pregnant women, newborns and infants. Immunization during pregnancy has the potential to provide protection to the newborn and i...

Impact Evaluation of Super Abbu: A Speech Based MNCH Platform in Pakistan
https://clinicaltrials.gov/ct2/show/NCT04008199

Jun 15th, 2022 - Problem: Pakistan has the highest neonatal mortality rate in the world (44.2 per 1000 live births), accounting for 7% of the world's neonatal deaths, and among the worst maternal mortality rate in the region (178 per 100,000 live births). These in...

Long-Term PF-06651600 for the Treatment of Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT04006457

Jun 13th, 2022 - This is a global Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have alopecia areata. Eligible patients from the prior studies B793100...

see more →

News  561 results

Antibiotics use and vaccine antibody levels
https://www.mdedge.com/pediatrics/article/253722/vaccines/antibiotics-use-and-vaccine-antibody-levels
Michael E. Pichichero, MD

May 1st, 2022 - In this column I have previously discussed the microbiome and its importance to health, especially as it relates to infections in children. Given the appreciated connection between microbiome and immunity, my group in Rochester, N.

Routine Childhood Vaccinations Dropped 1% During Pandemic
https://www.medscape.com/viewarticle/972624

Apr 22nd, 2022 - The vaccination rate among kindergartners fell to around 94% during the 2020-21 school year, a drop of about 1% from the previous school year, the CDC said Thursday. Nationally, 93.9% of children received two doses of measles, mumps, and rubella v...

CDC Finds 'Concerning' Dip in Kindergartener Vaccination Coverage
https://www.medpagetoday.com/pediatrics/vaccines/98343

Apr 21st, 2022 - Vaccination rates among kindergarteners dipped below the public health target of 95% during the 2020-2021 school year, the CDC said. National coverage was 93.9% for the two-dose measles, mumps, and rubella (MMR) vaccine, 93.6% for the state-requir...

EU Sets Up Distribution Centres on Ukraine Border for Refugees Needing Care
https://www.medscape.com/viewarticle/971112

Mar 30th, 2022 - (Reuters) - The European Union is setting up centres on its borders to Ukraine to receive and distribute refugees in need of healthcare to member states best placed for treating them, the EU health commissioner said on Tuesday. "We are working clo...

History of diphtheria or tetanus vaccination linked to lower risk for severe COVID-19
https://www.mdedge.com/icymi-covid/article/248715/covid-19/history-diphtheria-or-tetanus-vaccination-linked-lower-risk

Nov 15th, 2021 - Key clinical point: Individuals who had received diphtheria or tetanus vaccinations in the last 10 years were less likely to develop severe COVID-19 compared with those who had not received them. Major finding: The study included 103,049 participa.

see more →

Patient Education  11 results see all →